Literature DB >> 25944521

Prevalence of postmenopausal symptoms in North America and Europe.

Mary Jane Minkin1, Suzanne Reiter, Ricardo Maamari.   

Abstract

OBJECTIVE: This study aims to evaluate differences and similarities in the prevalence of postmenopausal symptoms and their impact on postmenopausal women and male partners of postmenopausal women in North America and Europe.
METHODS: The Internet-based survey Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) was conducted in North America and Europe. The questionnaire included questions on symptoms experienced by women after menopause and the impact of these symptoms overall and specifically on emotional and physical relationships. This study included 8,200 respondents: 4,100 were postmenopausal women who had experienced vaginal discomfort and 4,100 were male partners of postmenopausal women with this symptom. Differences were significant at the 95% level of confidence.
RESULTS: The survey identified vaginal dryness, hot flashes, night sweats, disrupted sleep, and weight gain as the top five symptoms experienced by postmenopausal women in North America and Europe. Overall, symptoms were found to be more prevalent in women from the United States, United Kingdom, and Canada (P < 0.05), and less prevalent in women from Sweden and Italy compared with other countries. In regards to the impact of symptoms overall and on emotional and physical relationships, the greatest number of women from the United States, United Kingdom, and Canada found the impact to be "worse than expected."
CONCLUSIONS: The impact of postmenopausal symptoms on relationships is greater in women from countries where symptoms are more prevalent. Postmenopausal women and male partners of postmenopausal women may benefit from greater education about menopause and open discussions with their healthcare provider.

Entities:  

Mesh:

Year:  2015        PMID: 25944521     DOI: 10.1097/GME.0000000000000464

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  9 in total

1.  Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.

Authors:  Susan J Diem; Katherine A Guthrie; Caroline M Mitchell; Susan D Reed; Joseph C Larson; Kristine E Ensrud; Andrea Z LaCroix
Journal:  Menopause       Date:  2018-10       Impact factor: 2.953

2.  Clinical trial shows lasting function of a new moisturizing cream against vaginal dryness.

Authors:  Hans-Heinrich Henneicke-von Zepelin; Ragna Williams; Wiebke Havemeister; Walter Wigger-Alberti; Klaus-Ulrich Nolte
Journal:  Wien Med Wochenschr       Date:  2017-01-13

3.  Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem.

Authors:  Caroline M Mitchell; Sujatha Srinivasan; Anna Plantinga; Michael C Wu; Susan D Reed; Katherine A Guthrie; Andrea Z LaCroix; Tina Fiedler; Matthew Munch; Congzhou Liu; Noah G Hoffman; Ian A Blair; Katherine Newton; Ellen W Freeman; Hadine Joffe; Lee Cohen; David N Fredricks
Journal:  Menopause       Date:  2018-05       Impact factor: 2.953

4.  Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial.

Authors:  Caroline M Mitchell; Susan D Reed; Susan Diem; Joseph C Larson; Katherine M Newton; Kristine E Ensrud; Andrea Z LaCroix; Bette Caan; Katherine A Guthrie
Journal:  JAMA Intern Med       Date:  2018-05-01       Impact factor: 21.873

5.  Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis.

Authors:  Caroline M Mitchell; Sujatha Srinivasan; Xiang Zhan; Michael C Wu; Susan D Reed; Katherine A Guthrie; Andrea Z LaCroix; Tina Fiedler; Matthew Munch; Congzhou Liu; Noah G Hoffman; Ian A Blair; Katherine Newton; Ellen W Freeman; Hadine Joffe; Lee Cohen; David N Fredricks
Journal:  Menopause       Date:  2017-10       Impact factor: 3.310

6.  The relationship between social support, stressful events, and menopause symptoms.

Authors:  Megan Arnot; Emily H Emmott; Ruth Mace
Journal:  PLoS One       Date:  2021-01-27       Impact factor: 3.240

7.  Patient-centered change in the day-to-day impact of postmenopausal vaginal symptoms: results from a multicenter randomized trial.

Authors:  Carolyn J Gibson; Alison J Huang; Joseph C Larson; Caroline Mitchell; Susan Diem; Andrea LaCroix; Katherine M Newton; Susan D Reed; Katherine A Guthrie
Journal:  Am J Obstet Gynecol       Date:  2020-01-15       Impact factor: 8.661

8.  Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.

Authors:  James A Simon; Corrado Altomare; Susannah Cort; Wei Jiang; JoAnn V Pinkerton
Journal:  J Womens Health (Larchmt)       Date:  2017-10-24       Impact factor: 2.681

Review 9.  Microbiomes other than the gut: inflammaging and age-related diseases.

Authors:  Aurelia Santoro; Jiangchao Zhao; Lu Wu; Ciriaco Carru; Elena Biagi; Claudio Franceschi
Journal:  Semin Immunopathol       Date:  2020-09-30       Impact factor: 9.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.